Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 19

1.

Initial assessment of the benefits of implementing pharmacogenetics into the medical management of patients in a long-term care facility.

Saldivar JS, Taylor D, Sugarman EA, Cullors A, Garces JA, Oades K, Centeno J.

Pharmgenomics Pers Med. 2016 Jan 19;9:1-6. doi: 10.2147/PGPM.S93480. eCollection 2016.

2.

Association between use of warfarin with common sulfonylureas and serious hypoglycemic events: retrospective cohort analysis.

Romley JA, Gong C, Jena AB, Goldman DP, Williams B, Peters A.

BMJ. 2015 Dec 7;351:h6223. doi: 10.1136/bmj.h6223.

3.

Trends and interaction of polypharmacy and potentially inappropriate prescribing in primary care over 15 years in Ireland: a repeated cross-sectional study.

Moriarty F, Hardy C, Bennett K, Smith SM, Fahey T.

BMJ Open. 2015 Sep 18;5(9):e008656. doi: 10.1136/bmjopen-2015-008656.

4.

Polypharmacy Among Adults Aged 65 Years and Older in the United States: 1988-2010.

Charlesworth CJ, Smit E, Lee DS, Alramadhan F, Odden MC.

J Gerontol A Biol Sci Med Sci. 2015 Aug;70(8):989-95. doi: 10.1093/gerona/glv013. Epub 2015 Mar 1.

PMID:
25733718
5.

Health outcomes associated with polypharmacy in community-dwelling older adults: a systematic review.

Fried TR, O'Leary J, Towle V, Goldstein MK, Trentalange M, Martin DK.

J Am Geriatr Soc. 2014 Dec;62(12):2261-72. doi: 10.1111/jgs.13153. Review.

6.

Pharmacy interventions on prescribing in nursing homes: from evidence to practice.

Hughes CM, Lapane KL.

Ther Adv Drug Saf. 2011 Jun;2(3):103-12. doi: 10.1177/2042098611406167. Review.

7.

Polypharmacy and potentially inappropriate medication use in older adults with cancer undergoing chemotherapy: effect on chemotherapy-related toxicity and hospitalization during treatment.

Maggiore RJ, Dale W, Gross CP, Feng T, Tew WP, Mohile SG, Owusu C, Klepin HD, Lichtman SM, Gajra A, Ramani R, Katheria V, Zavala L, Hurria A; Cancer and Aging Research Group.

J Am Geriatr Soc. 2014 Aug;62(8):1505-12. doi: 10.1111/jgs.12942. Epub 2014 Jul 15.

8.

Going beyond the numbers - a call to redefine polypharmacy.

Hughes CM, Cooper JA, Ryan C.

Br J Clin Pharmacol. 2014 Jun;77(6):915-6. doi: 10.1111/bcp.12284. No abstract available.

9.

Medication burden of Saudi Arabian women receiving antiresorptive therapy.

Sadat-Ali M, Al-Shafie B, Al-Omran AS, Azam MQ.

Int J Womens Health. 2012;4:433-6. doi: 10.2147/IJWH.S33287. Epub 2012 Aug 28.

10.

Effect of a pharmacist-led multicomponent intervention focusing on the medication monitoring phase to prevent potential adverse drug events in nursing homes.

Lapane KL, Hughes CM, Daiello LA, Cameron KA, Feinberg J.

J Am Geriatr Soc. 2011 Jul;59(7):1238-45. doi: 10.1111/j.1532-5415.2011.03418.x. Epub 2011 Jun 7.

11.

Managing medications in clinically complex elders: "There's got to be a happy medium".

Steinman MA, Hanlon JT.

JAMA. 2010 Oct 13;304(14):1592-601. doi: 10.1001/jama.2010.1482. Review.

12.

Qualitative insights into general practitioners views on polypharmacy.

Anthierens S, Tansens A, Petrovic M, Christiaens T.

BMC Fam Pract. 2010 Sep 15;11:65. doi: 10.1186/1471-2296-11-65.

13.

Primary care clinicians' experiences with treatment decision making for older persons with multiple conditions.

Fried TR, Tinetti ME, Iannone L.

Arch Intern Med. 2011 Jan 10;171(1):75-80. doi: 10.1001/archinternmed.2010.318. Epub 2010 Sep 13.

14.

Polypharmacy in older adults with cancer.

Maggiore RJ, Gross CP, Hurria A.

Oncologist. 2010;15(5):507-22. doi: 10.1634/theoncologist.2009-0290. Epub 2010 Apr 24. Review.

15.

Will hypertension performance measures used for pay-for-performance programs penalize those who care for medically complex patients?

Petersen LA, Woodard LD, Henderson LM, Urech TH, Pietz K.

Circulation. 2009 Jun 16;119(23):2978-85. doi: 10.1161/CIRCULATIONAHA.108.836544. Epub 2009 Jun 1.

16.

Health outcomes associated with potentially inappropriate medication use in older adults.

Fick DM, Mion LC, Beers MH, L Waller J.

Res Nurs Health. 2008 Feb;31(1):42-51. doi: 10.1002/nur.20232.

17.

Insufficient communication about medication use at the interface between hospital and primary care.

Glintborg B, Andersen SE, Dalhoff K.

Qual Saf Health Care. 2007 Feb;16(1):34-9.

19.

Polypharmacy as commonly defined is an indicator of limited value in the assessment of drug-related problems.

Viktil KK, Blix HS, Moger TA, Reikvam A.

Br J Clin Pharmacol. 2007 Feb;63(2):187-95. Epub 2006 Aug 30.

Items per page

Supplemental Content

Write to the Help Desk